|
humans |
14 |
|
male |
14 |
|
adult |
13 |
|
aged |
13 |
|
female |
13 |
|
middle aged |
12 |
|
lipocalin-2 |
11 |
|
medical sciences |
11 |
|
adipocyte |
10 |
|
adiponectin |
10 |
|
coronary artery disease |
10 |
|
fibroblast growth factor |
10 |
|
metabolic syndrome |
10 |
|
obesity |
10 |
|
risk factor |
10 |
|
adiposity - physiology |
9 |
|
risk factors |
9 |
|
body mass index |
8 |
|
diabetes |
8 |
|
anti-steatosis |
7 |
|
c-reactive protein |
7 |
|
cell survival signaling |
7 |
|
chinese |
7 |
|
fatty liver - pathology - surgery |
7 |
|
graft rejection - blood - drug therapy - pathology |
7 |
|
graft survival - drug effects |
7 |
|
hepatic microcirculation |
7 |
|
immunosuppressive agents - therapeutic use |
7 |
|
liver transplantation |
7 |
|
marginal graft |
7 |
|
obesity - blood - complications |
7 |
|
prospective studies |
7 |
|
adiponectin - blood |
6 |
|
blood pressure - physiology |
6 |
|
case-control studies |
6 |
|
china - epidemiology |
6 |
|
cohort studies |
6 |
|
hypertension |
6 |
|
hypertension - blood - epidemiology |
6 |
|
inflammation |
6 |
|
insulin resistance - physiology |
6 |
|
prediction |
6 |
|
predictive value of tests |
6 |
|
adaptor proteins, signal transducing - antagonists and inhibitors - genetics - physiology |
5 |
|
atherosclerosis |
5 |
|
biological markers - blood |
5 |
|
carotid artery diseases - diagnosis |
5 |
|
carotid intima-media thickness |
5 |
|
china |
5 |
|
endothelin-1 - metabolism |
5 |
|
endothelium, vascular - drug effects - metabolism - physiopathology |
5 |
|
fatty acid-binding proteins - blood |
5 |
|
fatty-acid-binding proteins |
5 |
|
metabolic syndrome x - blood |
5 |
|
nitric oxide - metabolism |
5 |
|
obesity - blood |
5 |
|
obesity - physiopathology |
5 |
|
28 inflammation in type 2 diabetes |
4 |
|
a-fabp |
4 |
|
adipokines - blood |
4 |
|
adolescent |
4 |
|
alkaline phosphatase - metabolism |
4 |
|
appl1 |
4 |
|
asian continental ancestry group |
4 |
|
bariatric surgery - mortality |
4 |
|
beta-trace protein |
4 |
|
biomarker |
4 |
|
cardiovascular diseases - blood - epidemiology - etiology |
4 |
|
carrier proteins - blood |
4 |
|
diabetes mellitus, type 2 - prevention & control |
4 |
|
fatty liver - surgery |
4 |
|
ferritin |
4 |
|
gastric balloon |
4 |
|
gastric bypass - statistics & numerical data |
4 |
|
gastroplasty - statistics & numerical data |
4 |
|
glycoproteins - blood |
4 |
|
hepatic stellate cells |
4 |
|
hyperparathyroidism - complications - diagnosis |
4 |
|
hypophosphatemia - etiology |
4 |
|
insulin |
4 |
|
iron |
4 |
|
liver fibrosis |
4 |
|
liver sinusoidal endothelial cells |
4 |
|
metabolic syndrome x - blood - etiology |
4 |
|
nhanes iii |
4 |
|
obesity - surgery |
4 |
|
parathyroidectomy |
4 |
|
pharmacy and pharmacology environmental studies |
4 |
|
pre-diabetes |
4 |
|
prevalence |
4 |
|
tgfβ1 |
4 |
|
toxicology and environmental safety |
4 |
|
transferrin saturation |
4 |
|
triglycerides - blood |
4 |
|
vitamin d - therapeutic use |
4 |
|
weight loss - physiology |
4 |
|
adipocyte fatty acid-binding protein |
3 |
|
adipokine |
3 |
|
adiponectin - metabolism |
3 |
|
advanced glycation end-products |
3 |
|
aldehyde reductase - metabolism |
3 |
|
aldose reductase gene |
3 |
|
alpha 2 macroglobulin |
3 |
|
amino acid sequence |
3 |
|
animals |
3 |
|
apolipoproteins |
3 |
|
blood proteins - chemistry - metabolism |
3 |
|
body composition |
3 |
|
cardiovascular disease |
3 |
|
cell culture techniques |
3 |
|
cell line |
3 |
|
chemicals and cas registry numbers |
3 |
|
cholesterol |
3 |
|
chromatography, affinity |
3 |
|
chromatography, liquid |
3 |
|
clarity |
3 |
|
collagen type iv - biosynthesis - physiology |
3 |
|
cox regression |
3 |
|
cyclic amp - metabolism |
3 |
|
diabetes incidence |
3 |
|
diabetic glomerulopathy |
3 |
|
diabetic nephropathies - physiopathology |
3 |
|
diabetic nephropathy |
3 |
|
electrophoresis, gel, two-dimensional |
3 |
|
fasting glucose |
3 |
|
gait |
3 |
|
gene expression regulation |
3 |
|
glycosylation end products, advanced - physiology |
3 |
|
haemoglobin a1c |
3 |
|
heterozygote |
3 |
|
hormone |
3 |
|
kidney glomerulus - cytology - pathology |
3 |
|
l-iditol 2-dehydrogenase |
3 |
|
mass spectrometry |
3 |
|
mice |
3 |
|
mice, transgenic |
3 |
|
molecular sequence data |
3 |
|
mutagenesis, site-directed |
3 |
|
mutation, missense |
3 |
|
obesity - genetics - metabolism |
3 |
|
pancreas |
3 |
|
pedigree |
3 |
|
polymorphism, genetic |
3 |
|
polymorphism, restriction fragment length |
3 |
|
protein binding |
3 |
|
proteome |
3 |
|
radioactive iodine |
3 |
|
receptor, melanocortin, type 4 - genetics - metabolism |
3 |
|
reverse transcriptase polymerase chain reaction |
3 |
|
rna, messenger - analysis - biosynthesis |
3 |
|
sarcopenia |
3 |
|
sensitivity and specificity |
3 |
|
serum albumin, bovine |
3 |
|
signal transduction |
3 |
|
simple |
3 |
|
tgf-β 1 |
3 |
|
three-dimensional imaging |
3 |
|
thrombospondin-1 |
3 |
|
thyrotoxicosis |
3 |
|
tissue clearing |
3 |
|
transfection |
3 |
|
transfection - methods |
3 |
|
transforming growth factor beta - physiology |
3 |
|
transforming growth factor beta1 |
3 |
|
transgenic mouse |
3 |
|
type iv collagen |
3 |
|
糖尿(glycosuria) |
3 |
|
糖尿病(diabetes mellitus) |
3 |
|
糖尿病1型(diabetes mellitus, type 1) |
3 |
|
都市化(urbanization) |
3 |
|
香港(hong kong) |
3 |
|
adiponectin - blood - chemistry |
2 |
|
adipose tissue - cytology - metabolism |
2 |
|
adipose tissue - metabolism |
2 |
|
administration, inhalation |
2 |
|
adrenal cortex hormones - administration & dosage - therapeutic use |
2 |
|
adrenal gland neoplasms - complications |
2 |
|
aging |
2 |
|
asthma |
2 |
|
asthma - blood - drug therapy |
2 |
|
blood glucose - metabolism |
2 |
|
bone density - drug effects |
2 |
|
bone loss |
2 |
|
bone mineral density |
2 |
|
calcium - administration & dosage - blood |
2 |
|
carbamylation |
2 |
|
cardiometabolic disorders |
2 |
|
corticosteroid |
2 |
|
cross-sectional studies |
2 |
|
cyanate |
2 |
|
diabetes mellitus - epidemiology |
2 |
|
diet |
2 |
|
diet records |
2 |
|
dietary carbohydrates - administration & dosage |
2 |
|
educational status |
2 |
|
energy intake |
2 |
|
estradiol - blood |
2 |
|
etidronate |
2 |
|
exercise |
2 |
|
fruit |
2 |
|
gene expression |
2 |
|
glucose - metabolism |
2 |
|
glucose intolerance - epidemiology |
2 |
|
glucose tolerance |
2 |
|
glucose tolerance test |
2 |
|
growth hormone-releasing hormone - genetics - metabolism |
2 |
|
homeostasis - physiology |
2 |
|
hong kong - epidemiology |
2 |
|
hypothalamus - metabolism |
2 |
|
hypothyroidism - genetics - metabolism |
2 |
|
insulin - blood |
2 |
|
isomerism |
2 |
|
killer cells, natural - metabolism |
2 |
|
linear models |
2 |
|
lipoprotein |
2 |
|
longitudinal studies |
2 |
|
macrophages - cytology |
2 |
|
molecular weight |
2 |
|
multivariate analysis |
2 |
|
myasthenia gravis - chemically induced - complications |
2 |
|
myeloperoxidase |
2 |
|
obesity - complications |
2 |
|
oryza sativa |
2 |
|
pharmacological intervention |
2 |
|
pheochromocytoma - complications |
2 |
|
pituitary gland, anterior - metabolism |
2 |
|
pregnancy |
2 |
|
progesterone - blood |
2 |
|
propranolol - adverse effects |
2 |
|
questionnaires |
2 |
|
sex factors |
2 |
|
signaling |
2 |
|
therapeutic target |
2 |
|
uraemia |
2 |
|
vegetables |
2 |
|
coronary disease - epidemiology - prevention & control |
1 |
|
diabetes mellitus, type 2 - drug therapy - epidemiology |
1 |
|
diabetic angiopathies - epidemiology - prevention & control |
1 |
|
hemoglobin a, glycosylated - analysis |
1 |
|
hyperglycemia - prevention & control |
1 |
|
hypoglycemic agents - adverse effects - therapeutic use |
1 |
|
metformin - therapeutic use |
1 |
|
sulfonylurea compounds - therapeutic use |
1 |
|
trisaccharides - adverse effects - therapeutic use |
1 |
